Company intelligence / Profile preview

Suzhou Zhiyao Biotechnology

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Zhiyao Biotech is a biotechnology company headquartered in Suzhou, China, specializing in AI-driven drug discovery (AIDD). The company integrates advanced computational methods with structural biology and medicinal chemistry to develop innovative small molecule drugs. Its primary focus areas include oncology and autoimmune diseases, with a pipeline featuring inhibitors for targets such as USP1, HPK1, and TYK2. Zhiyao Biotech has secured significant venture capital funding to advance its proprietary platform and transition its lead programs into clinical development.

Therapeutic areas: OncologyImmunology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Suzhou Zhiyao Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suzhou Zhiyao Biotechnology.

Explore the full profile